A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor by 류철형
66  Copyright © 2020 The Korean Movement Disorder Society
LETTER TO THE EDITOR
https://doi.org/10.14802/jmd.19038  /  J Mov Disord  2020;13(1):66-68
pISSN 2005-940X / eISSN 2093-4939
JMD
Dear Editor,
Neurodegeneration with brain iron accumulation (NBIA) re-
fers to a group of rare diseases that share clinical characteristics 
associated with excessive iron accumulation in the basal gan-
glia as well as progressive neurological deficits, such as chorea, 
dystonia, parkinsonism and cognitive impairment. Neuroferri-
tinopathy is a form of NBIA caused by mutations in the ferritin 
light chain (FTL1) gene on chromosome 19q13.3. The most 
common initial clinical manifestations of neuroferritinopathy 
are chorea and dystonia, and only six patients have been de-
scribed who initially presented with tremor.1 Here, we report a 
neuroferritinopathy patient who exhibited early prominent voice 
tremor and carried an insertional mutation in the FTL1 gene. 
This study was approved by the institutional review board of 
Gangnam Severance Hospital (3-2019-0057).
A 27-year-old woman visited our movement disorders clinic 
for severe voice tremor and mild hand tremor. She reported first 
experiencing a mild voice tremor at 13 years of age. Her voice 
tremor began to progressively worsen in her early 20s, and she 
had since experienced hand tremors most commonly when 
holding a cup or spoon. She was the second child of two sib-
lings, and her birth, perinatal, and developmental histories 
were not remarkable. Her father also experienced severe hand 
tremors that began in his 30s and died of suspected parkinson-
ism in his mid-40s. Her mother and elder brother showed no 
abnormalities on neurological examination. Although her speech 
volume was almost normal, she spoke with a severe voice trem-
or without breaks in her voice. When sitting on a chair, she ex-
hibited mild cervical dystonia that caused a slight turning of 
her head leftward and a continuous mild head tremor. When her 
arms and hands were extended or positioned under the nose, 
she showed mild dystonic hyperextension of both fingers and 
fine postural tremor with her left fingers. She also showed mild 
kinetic tremor in both hands. Rigidity was absent. Her hand-
rolling and finger-tapping movement was normal, and she was 
able to walk with a normal gait. She had normal cognition, and 
her thyroid function tests and ceruloplasmin levels were normal. 
However, her serum iron (23 μg/dL, reference 60–180 μg/dL) 
and ferritin (3.8 ng/mL, reference 10–122 ng/mL) levels were 
lower than the normal range. A susceptibility-weighted brain 
magnetic resonance (MR) imaging study showed hypointense 
lesions in the bilateral globus pallidus, thalamus, substantia 
nigra, red nucleus, and dentate nucleus without cavitary lesions. 
In addition, there were thin hypointense lines along the junc-
tions between the diffuse cortical gray and white matter, sug-
gesting a pencil lining sign (Figure 1A). Whole-genome se-
quencing and subsequent confirmatory Sanger sequencing of 
the FTL1 gene revealed a 16-bp insertional mutation in exon 4 
(c.469_484het_dup16nt, NM_000146.3), that caused a frame-
shift and early termination of transcription after the insertion 
of 5 amino acids (p. G156GGPEAGX, NP_000137.2) (Figure 1B). 
This mutation was not present in her mother or elder brother. 
Her voice tremor did not respond to several trials of injection 
of botulinum toxin into the adductor muscles of the vocal cord. 
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Figure 1. Brain MRI and DNA sequence of the neuroferritinopathy patient. (A) Susceptibility-weighted magnetic resonance (MR) images 
(SWI) showing low signal intensity lesions in the bilateral globus pallidus, thalamus, substantia nigra, red nucleus, and dentate nucleus. 
Pencil lining signs were observed around the junction between the cortical gray and white matter. T2-weighted image MR images showing 
slightly increased hypointense lesions in the same subcortical nuclei, while fluid-attenuated inversion recovery (FLAIR) images showed no 
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Propranolol and trihexyphenidyl were also not effective at re-
ducing voice tremors and hand tremors. Her tremor was slight-
ly reduced by small doses of zonisamide (50 mg twice a day).
Eleven mutations in the FTL1 gene have been reported in 
more than 90 patients with neuroferritinopathy.1-3 In these pa-
tients, six patients in two families presented with tremor as an 
initial clinical symptom. Four French patients harboring the 
c.497_498dupTC mutation initially presented with hand trem-
ors beginning in their 20s or 40s and later developed various 
other motor symptoms, including cerebellar dysfunction, cho-
rea, dystonia, or parkinsonism.4 Two Japanese patients with the 
same FTL1 mutation (c.469_484het_dup16nt) found in our 
patient presented with hand tremor as an initial symptom at 
ages 10 and 15 years old and later developed parkinsonism and 
cognitive impairment in their mid-30s.5 Unlike these patients, 
our patient showed an early prominent voice tremor rather than 
hand tremor. In addition to these Japanese patients, one Italian 
patient with the same 469_484het_dup16nt mutation present-
ed with reports of frequent falls and behavioral changes in his 
20s, and that patient later developed dystonia, parkinsonism, 
cerebellar ataxia and hand tremor.6 Unlike these Japanese and 
Italian patients, who commonly showed cavitary lesions in the 
pallidum and striatum, our patient exhibited iron accumula-
tion in the subcortical nuclei and a pencil lining sign without 
cavitary lesions, possibly due to a shorter disease duration and 
milder clinical symptoms. However, it is worth noting that all 
patients with the c.469_484het_dup16nt mutation, which causes 
a conformational change in the helix-E of the ferritin light chain 
protein, commonly showed their initial symptoms early in life 
(in their teens or 20s) and then progressed to show parkinson-
ism and cognitive impairment, while patients with other types 
of FTL1 mutations that cause conformational changes in the 
helix-D tend to become symptomatic in their 30s to 50s and to 
develop a relatively milder phenotype.1,7 Our patient might be 
too young to show additional signs of parkinsonism and cog-
nitive impairment, considering the later development of par-
kinsonism observed in her father. Long-term follow-up is re-
quired to monitor additional symptoms and the appearance of 
cavitary lesions on MR imaging.
To our knowledge, this is the first report of a neuroferriti-
nopathy patient who presented with voice tremor as an initial 
and prominent clinical symptom. Neuroferritinopathy may be 
considered as a differential diagnosis, particularly in patients 
presenting with juvenile-onset voice tremor.
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